Jade Biosciences, Inc.
JBIO
$13.66
-$0.32-2.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -26.84% | 21.66% | 15.81% | ||
| Total Depreciation and Amortization | -25.00% | 500.00% | -137.50% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 114.72% | -59.58% | -43.03% | ||
| Change in Net Operating Assets | -889.48% | -158.36% | 15.43% | ||
| Cash from Operations | -52.09% | -9.75% | -7.47% | ||
| Capital Expenditure | 94.74% | 58.09% | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 33.97% | -- | -- | ||
| Cash from Investing | 33.99% | -109,244.12% | -- | ||
| Total Debt Issued | -1,209.13% | -107.10% | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -270.28% | 206.25% | -1,856.00% | ||
| Cash from Financing | -- | -100.00% | 27,429.71% | ||
| Foreign Exchange rate Adjustments | -325.00% | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 122.44% | -199.90% | 978.93% | ||